Previous Article | Next Article ![]()
Infection and Immunity, November 2000, p. 6355-6361, Vol. 68, No. 11
Department of Clinical Analyses, State
University of Maringá, Maringá, Paraná,1
and Department of Immunology, Institute of Biomedical
Sciences, University of São Paulo, São
Paulo,2 Brazil
Received 13 April 2000/Returned for modification 5 June
2000/Accepted 1 August 2000
In the present study we investigated the role of
platelet-activating factor (PAF) and prostaglandins in
experimental Leishmania (Leishmania)
amazonensis infection and the relationship between these
mediators and nitric oxide (NO) production. Mouse peritoneal macrophages elicited with thioglicolate were infected with
leishmania amastigotes, and the infection index determined 48 h later. The course of infection was monitored for 5 weeks in mice
infected in the footpad with promastigotes by measuring the footpad
swelling and parasite load in regional lymph nodes and spleen. The
addition of PAF to C57BL/6 mouse macrophages significantly inhibited
parasite growth and induced NO production. Treatment of macrophages
with a selective PAF antagonist, WEB2086, increased the
infection, indicating that endogenously produced PAF regulates
macrophage ability to control leishmania infection. This
effect of PAF was abolished by addition of the inhibitor of NO
synthesis, L-NAME, to the cultures. The addition of prostaglandin
E2 significantly increased the infection and NO production.
Treatment with cyclo-oxygenase inhibitor, indomethacin, reduced the
infection and PAF-induced release of NO. Thus, the increased NO
production induced by PAF seems to be mediated by prostaglandins. The
more-selective inhibitors of cyclo-oxygenase 2, nimesulide and NS-398,
had no significant effect. Thus, antileishmanial activity
correlates better with the presence of PAF or absence of prostaglandins
than with NO production. In vivo treatment with PAF
antagonists significantly increased leishmania lesions, as well as
the parasite load, in regional lymph nodes and spleens. These
findings indicate that PAF is essential for the control of leishmania infection.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Essential Role of Platelet-Activating Factor in
Control of Leishmania (Leishmania)
amazonensis Infection
*
Corresponding author. Mailing address: Department of
Immunology, ICB/USP, Av. Prof. Lineu Prestes, 1730, CEP 05508-900, São Paulo, SP, Brazil. Phone: 55-11-3818-7393. Fax:
55-11-3818-7224. E-mail: sojancar{at}icb.usp.br.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»